Indication:
Focus:
Chronic Pain
Remoxy® A novel drug candidate to deter oxycodone abuse.
Learn more View complete product pipeline
January 05, 2012DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
January 05, 2012Durect Corp to Discuss POSIDUR Clinical Trial Results
November 07, 2011DURECT Corporation to Participate in Upcoming Healthcare Conferences
November 03, 2011DURECT Corporation Announces Third Quarter 2011 Financial Results and Update of Programs
October 26, 2011DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
September 10, 2011DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR(R) (BESST)
September 06, 2011DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)